BDBM39625 4-[4-(furan-2-yl)-6-(trifluoromethyl)pyrimidin-2-yl]sulfanyl-N-(5-methyl-1,2-oxazol-3-yl)butanamide::4-[[4-(2-furanyl)-6-(trifluoromethyl)-2-pyrimidinyl]thio]-N-(5-methyl-3-isoxazolyl)butanamide::4-[[4-(2-furyl)-6-(trifluoromethyl)pyrimidin-2-yl]thio]-N-(5-methylisoxazol-3-yl)butyramide::4-{[4-(2-furyl)-6-(trifluoromethyl)-2-pyrimidinyl]thio}-N-(5-methyl-3-isoxazolyl)butanamide::MLS000052722::SMR000082479::cid_2982425

SMILES CNC(=O)c1cc2ccc1Nc1nc(ncc1C(F)(F)F)Nc1ccc(OC)c(c1)OC/C=C\CCCO2

InChI Key InChIKey=WZXRSGMXJJLRNL-UHFFFAOYSA-N

Data  1 IC50  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 39625   

TargetSerine/threonine-protein kinase ULK1(Human)
Salk Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 39625BDBM39625(US12594277, Compound 19)
Affinity DataIC50: 20nMAssay Description:Sanford-Burnham Center for Chemical Genomics (SBCCG) Sanford-Burnham Medical Research Institute (SBMRI, San Diego, CA) NIH Molecular Libraries Screen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2026
Entry Details
US Patent